Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand (Q28564458)
Jump to navigation
Jump to search
scientific journal article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand |
scientific journal article |
Statements
1 reference
Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand (English)
1 reference
Ryo Tatsumi
1 reference
Masakazu Fujio
1 reference
Hiroyuki Satoh
1 reference
Jiro Katayama
1 reference
Shin-Ichi Takanashi
1 reference
Kenji Hashimoto
1 reference
Hiroshi Tanaka
1 reference
1 reference
Identifiers
1 reference